Lupin Recalls Oseltamivir Phosphate Oral Suspension Due to Impurity Issues
Lupin Pharmaceuticals is recalling 46,479 bottles of Oseltamivir Phosphate oral suspension because out-of-specification test results were found for Impurity C during stability testing.
- Product
- OSELTAMIVIR PHOSPHATE — OSELTAMIVIR PHOSPHATE (OSELTAMIVIR PHOSPHATE)
- Category
- Drug
- Distribution
- Distributed nationwide